Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
December 8, 2019
[Travel vaccinations for certain groups of persons]
Kerstin Kling, Ole Wichmann, Gerd Burchard
Parasitology International
|
August 7, 2025
Ultrasonographic findings in Schistosoma mekongi infection. A minireview
Joachim Richter, Kerstin Kling, Christoph Hatz, et al.
Travel Medicine and Infectious Disease
|
May 19, 2016
Acute strongyloidiasis in a traveller returning from South East Asia
Kerstin Kling, Esther Kuenzli, Johannes Blum, et al.
Journal of Travel Medicine
|
May 3, 2025
Dengue virus infection in travellers after dengue vaccination, Germany 2023-24
Raskit Lachmann, Christina Frank, Hendrik Wilking, et al.
Swiss Medical Weekly
|
December 24, 2014
To vaccinate or let it be--current recommendations and the reality about yellow fever vaccination
Silja Bühler, Veronika K Jaeger, Kerstin Kling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 16, 2022
Reply to Martin and Dauby
Kerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Acta Tropica
|
January 1, 2020
Morbidity associated with Schistosoma mekongi and concurrent helminth infection in Lao People's Democratic Republic
Somphou Sayasone, Kerstin Kling, Phonesavanh Southisavath, et al.
Travel Medicine and Infectious Disease
|
March 26, 2023
Comment on: "New recommendation on yellow fever booster vaccination in Germany"
Kerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Journal of Travel Medicine
|
February 12, 2020
Vaccination against Japanese encephalitis with IC51: systematic review on immunogenicity, duration of protection and safety
Kerstin Kling, Thomas Harder, Zane Younger, et al.
Vaccine
|
January 21, 2026
Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya
Kerstin Kling, Annika Falman, Lisa Branke, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
December 8, 2019
[Travel vaccinations for certain groups of persons]
Kerstin Kling, Ole Wichmann, Gerd Burchard
Parasitology International
|
August 7, 2025
Ultrasonographic findings in Schistosoma mekongi infection. A minireview
Joachim Richter, Kerstin Kling, Christoph Hatz, et al.
Travel Medicine and Infectious Disease
|
May 19, 2016
Acute strongyloidiasis in a traveller returning from South East Asia
Kerstin Kling, Esther Kuenzli, Johannes Blum, et al.
Journal of Travel Medicine
|
May 3, 2025
Dengue virus infection in travellers after dengue vaccination, Germany 2023-24
Raskit Lachmann, Christina Frank, Hendrik Wilking, et al.
Swiss Medical Weekly
|
December 24, 2014
To vaccinate or let it be--current recommendations and the reality about yellow fever vaccination
Silja Bühler, Veronika K Jaeger, Kerstin Kling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 16, 2022
Reply to Martin and Dauby
Kerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Acta Tropica
|
January 1, 2020
Morbidity associated with Schistosoma mekongi and concurrent helminth infection in Lao People's Democratic Republic
Somphou Sayasone, Kerstin Kling, Phonesavanh Southisavath, et al.
Travel Medicine and Infectious Disease
|
March 26, 2023
Comment on: "New recommendation on yellow fever booster vaccination in Germany"
Kerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Journal of Travel Medicine
|
February 12, 2020
Vaccination against Japanese encephalitis with IC51: systematic review on immunogenicity, duration of protection and safety
Kerstin Kling, Thomas Harder, Zane Younger, et al.
Vaccine
|
January 21, 2026
Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya
Kerstin Kling, Annika Falman, Lisa Branke, et al.
Page
of 3